Inside a Mass Tort Case: What Your Legal Team Is Actually Doing

If you have submitted a mass tort claim, the months after filing can feel quiet from the outside. Behind the scenes, the opposite is true: mass tort litigation is one of the most labor-intensive forms of law practiced, and most of that labor happens in a phase called discovery. Understanding what your legal team is doing — and what the defense is doing to slow them down — makes the timeline much easier to live with.

Discovery is the court-supervised process where each side must hand over the evidence the other side asks for. In a mass tort, that means the plaintiffs' lawyers demand the company's internal records: safety studies, clinical trial data, adverse-event reports and the procedures for handling them, correspondence with regulators like the FDA, marketing materials, and internal emails. Defendants rarely make this easy. A common defense strategy is to stall — releasing documents as slowly as the rules allow, objecting to requests, or doing the opposite and dumping millions of pages in no useful order, hoping the important ones drown. Courts have tools for this: plaintiffs file motions to compel, judges can sanction obstruction, and companies can be required to index what they produce. Experienced mass tort firms expect this fight and start discovery demands immediately, often serving them with the complaint itself.

Much of the decisive evidence today is electronic. Emails, spreadsheets, databases, and backup tapes often contain what was really known inside a company and when — including messages that were "deleted" but remain recoverable. Plaintiffs' teams depose the people who run the defendant's records and IT systems to map where data lives, how it is backed up, and what was done to preserve it once litigation was on the horizon. Early in a case, lawyers also ask the court for preservation orders requiring the company to keep every potentially relevant document and file, because a record that is destroyed — even innocently — can never be evaluated. Defendants, for their part, frequently seek protective orders to keep records confidential, which courts grant only for genuinely sensitive material, not as a shield for embarrassing evidence.

Depositions are where documents turn into testimony. Company executives, scientists, sales personnel, former employees, and outside experts are questioned under oath, sometimes over many sessions across the litigation. What they admit — or cannot explain — often becomes the backbone of the case a jury eventually hears.

Expert witnesses are the other battleground, especially in drug and chemical cases where the core question is causation: did this product cause this disease? Under a Supreme Court decision called Daubert, trial judges act as gatekeepers who decide whether an expert's methods are scientifically reliable enough for a jury to hear. Defendants routinely try to knock out the plaintiffs' experts entirely, because a case that cannot prove causation cannot proceed. Winning these battles requires epidemiologists, toxicologists, and physicians backed by rigorous published science — one reason established mass torts, where the science has matured, move faster than brand-new ones.

All of this pressure builds toward resolution. Mass tort cases settle at a higher rate than ordinary injury suits, and trial dates are the engine: nothing motivates settlement talks like a jury waiting. Courts often schedule early "bellwether" trials — representative test cases whose outcomes show both sides what juries think the claims are worth. Some litigations end in a global settlement that resolves all claims at once, with individual payouts based on each person's injuries; famous cases have settled the day before trial. For any single claimant, the practical meaning is this: the process is slow because it is thorough, your case gains strength from every document and deposition won by the group, and you owe nothing along the way — participating firms are paid only as a percentage of an actual recovery.